Viemed Healthcare Inc VMD.OQ VMD.O is expected to show a rise in quarterly revenue when it reports results on November 5 for the period ending September 30 2025
The Lafayette Louisiana-based company is expected to report a 24.1% increase in revenue to $72 million from $58 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Viemed Healthcare Inc is for earnings of 9 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Viemed Healthcare Inc is $13.00, about 50.3% above its last closing price of $6.46
This summary was machine generated November 3 at 21:23 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments